MODERN ASPECTS OF TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE

MODERN ASPECTS OF TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE

Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease.Therefore,the treatment of NAFLD involves the use of drugs from different groups: omega-3 polyunsaturated fatty acids, statins, S-adenosylmethionine, ursodeoxycholic acid, essential phospholipids, metadoxine, glycyrrhizic acid, he...

Full description

Bibliographic Details
Main Author: R. G. Myazin
Format: Article
Language:Russian
Published: Remedium Group LLC 2017-11-01
Series:Медицинский совет
Subjects:
non-alcoholic fatty liver disease
biologically active additive hepaguard active®
Online Access:https://www.med-sovet.pro/jour/article/view/2062
id doaj-3a667bcd8ebd453c9180e7dec0bc00a2
record_format Article
spelling doaj-3a667bcd8ebd453c9180e7dec0bc00a22021-07-28T13:29:31ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902017-11-01015394210.21518/2079-701X-2017-15-39-422039MODERN ASPECTS OF TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASER. G. Myazin0Volgograd State Medical UniversityNon-alcoholic fatty liver disease (NAFLD) is a multifactorial disease.Therefore,the treatment of NAFLD involves the use of drugs from different groups: omega-3 polyunsaturated fatty acids, statins, S-adenosylmethionine, ursodeoxycholic acid, essential phospholipids, metadoxine, glycyrrhizic acid, herbal products, vitamin E and some others. In particular, the use of Hepaguard Active®, which has a high safety profile and good tolerability for use, is justified.https://www.med-sovet.pro/jour/article/view/2062non-alcoholic fatty liver diseasebiologically active additive hepaguard active®
collection DOAJ
language Russian
format Article
sources DOAJ
author R. G. Myazin
spellingShingle R. G. Myazin
MODERN ASPECTS OF TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
Медицинский совет
non-alcoholic fatty liver disease
biologically active additive hepaguard active®
author_facet R. G. Myazin
author_sort R. G. Myazin
title MODERN ASPECTS OF TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
title_short MODERN ASPECTS OF TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
title_full MODERN ASPECTS OF TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
title_fullStr MODERN ASPECTS OF TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
title_full_unstemmed MODERN ASPECTS OF TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
title_sort modern aspects of treatment of non-alcoholic fatty liver disease
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2017-11-01
description Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease.Therefore,the treatment of NAFLD involves the use of drugs from different groups: omega-3 polyunsaturated fatty acids, statins, S-adenosylmethionine, ursodeoxycholic acid, essential phospholipids, metadoxine, glycyrrhizic acid, herbal products, vitamin E and some others. In particular, the use of Hepaguard Active®, which has a high safety profile and good tolerability for use, is justified.
topic non-alcoholic fatty liver disease
biologically active additive hepaguard active®
url https://www.med-sovet.pro/jour/article/view/2062
work_keys_str_mv AT rgmyazin modernaspectsoftreatmentofnonalcoholicfattyliverdisease
_version_ 1721274127145238528

Similar Items